1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

Author(s):
Mackintosh, C.; Ordonez, J.L.; Garcia-Dominguez, D.J.; Sevillano, V.; Llombart-Bosch, A.; Szuhai, K. (0000-0002-1228-4245); Scotlandi, K.; Alberghini, M.; Sciot, R.; Sinnaeve, F.; Hogendoorn, P.C.W. (0000-0002-1513-8104); Picci, P.; Knuutila, S.; Dirksen, U.; Debiec-Rychter, M.; Schaefer, K.L.; Alava, E. de
Published
2012
Publication type
Article / Letter to editor
Ewing sarcoma1q GainCDT2clinical outcomemicroarrays
Date issued
2012-03-31
Language
English
Is part of
Oncogene (2012), Vol. 31, no. 10, p. 1287-1298
hdl
1887/98951
doi
10.1038/onc.2011.317